Tanshinone IIA reduces the risk of Alzheimer’s disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer’s disease

Ping Jiang, Chunbo Li, Zhenghua Xiang, Binghua JiaoMolecular 2014 · DOI

Abstract

Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline and neuroinflammation. Tanshinone IIA (Tan IIA), a major active constituent of Salvia miltiorrhiza, has shown neuroprotective potential, but its molecular mechanisms remain under investigation. This study utilized a rat model of AD, established via amyloid-beta (Aβ) injection, to evaluate the effects of Tan IIA. Results demonstrate that Tan IIA significantly improves spatial learning and memory while inhibiting the transcription and translation of inflammatory markers iNOS, MMP-2, and NF-κBp65 in the temporal lobe. These findings suggest that Tan IIA exerts its neuroprotective effects by suppressing the NF-κB signaling pathway.

Introduction

Alzheimer’s Disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) plaques and subsequent neuroinflammation, particularly affecting the temporal lobe—a region critical for memory. While previous research suggested that Tanshinone IIA (Tan IIA) possesses neuroprotective properties, the specific molecular pathways involved were not fully understood. This study investigates whether Tan IIA can interfere with the NF-κB pathway, a master regulator of inflammation that controls genes such as iNOS (inducible nitric oxide synthase) and MMP-2 (matrix metalloproteinase-2).

Methods

The researchers established an AD model in Sprague-Dawley rats by injecting Aβ protein into the lateral ventricle. The rats were divided into four groups: Control, Sham, AD, and Tan IIA (treated with 50 mg/kg/day).

  • Behavioral Testing: The Morris water maze was used to measure "escape latency," assessing spatial learning and memory.
  • Molecular Analysis: Quantitative PCR (qPCR) and Western blotting were employed to detect the mRNA and protein expression levels of iNOS, MMP-2, and NF-κBp65 in temporal lobe tissues.
  • Correlation Analysis: Spearman’s correlation was used to analyze the relationships between the expression levels of these markers.

Key Results

Cognitive Recovery

Rats in the AD group showed significant disruptions in learning and memory. Treatment with Tan IIA evidently reduced these symptoms, as evidenced by a significant decrease in escape latency compared to the untreated AD group.

Figure 2: Escape latency (sec) in the Morris water maze across five days of training, showing improvement in the Tan IIA group.

Molecular Suppression of Inflammatory Markers

Molecular analysis revealed that Aβ injection caused a massive upregulation of iNOS, MMP-2, and NF-κBp65 at both the transcriptional and translational levels. Tan IIA treatment significantly inhibited this upregulation, bringing protein expression levels back toward those of the control group.

Figure 4: Western blot analysis (A) and quantified protein expression (B) of iNOS, MMP-2, and NF-κBp65 across experimental groups.

Discussion and Insights

The study confirms that NF-κBp65 is a key upstream activator in AD-related neuroinflammation. Tan IIA acts as a multi-level inhibitor, targeting the inflammatory cascade at both the mRNA (transcription) and protein (translation) levels. The strong positive correlation found between NF-κBp65 and the other markers (iNOS and MMP-2) supports the hypothesis that Tan IIA disrupts a unified pathological pathway, specifically the NF-κB signaling pathway, to preserve temporal lobe function.

Limitations and Future Work

While promising, this study uses an acute Aβ-injection model, which may not fully replicate the chronic, decades-long progression of human AD. Furthermore, while the NF-κB pathway was identified as a target, the exact biochemical interaction between Tan IIA and NF-κB requires further study. Clinical trials are necessary to determine if these results translate effectively to human patients.

Summary updated

Abstract

Tanshinone IIA (Tan IIA), one of the major active constituents of the medicinal herb Salvia miltiorrhiza, has been reported to possess neuroprotective effects against the pathological features of Alzheimer's disease (AD), but the molecular mechanism underlying this effect remains unclear. To examine the effect of Tan IIA on AD, as well as the underlying molecular mechanisms, in vivo animal experiments and in vitro molecular biology investigations were employed in the present study. Firstly, a rat model of AD was successfully established by direct injection of the amyloid beta protein (Aβ) and then these rats were administered an interventional treatment of Tan IIA. The learning and memory ability of rats was evaluated in four groups (Control, Sham, AD and Tan IIA) utilizing a Morris water maze test. Quantitative (q)PCR was employed to detect the mRNA expression of inducible nitric oxide synthase (iNOS), matrix metalloproteinase‑2 (MMP‑2) and nuclear transcription factor kappa (NF‑κBp65) in temporal lobe tissues and protein expression was determined with western blot analysis. In addition, association analyses between iNOS, MMP‑2 and NF‑κBp65 at a transcriptional and translational level were performed utilizing Spearman's correlation analysis. In the present study, the results revealed that rats in the AD group demonstrated significant disruptions in learning and memory ability, and the symptoms were evidently reduced by Tan IIA. Furthermore, the upregulation of iNOS, MMP‑2 and NF‑κBp65 at a transcriptional and translational level in AD rats was distinctly inhibited by Tan IIA. Therefore, it was concluded that iNOS, MMP‑2 and NF‑κBp65 are involved in AD development, and Tan IIA may reduce AD risk by inhibiting transcription and translation of these genes. Furthermore, the positive correlation of iNOS and MMP‑2 with NF‑κBp65, respectively, provides evidence supporting the hypothesis that Tan IIA reduces AD risk by inhibiting iNOS and MMP‑2 at a transcriptional and translational level through the NF‑κB pathway. In summary, Tan IIA is an effective neuroprotective agent for AD therapy, and iNOS, MMP‑2 and NF‑κBp65 may be the potential molecular targets for manipulating this effect therapeutically.
BibTeX
@inproceedings{jiang2014tanshinone,
  author = {Ping Jiang and Chunbo Li and Zhenghua Xiang and Binghua Jiao},
  title = {{Tanshinone IIA reduces the risk of Alzheimer’s disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer’s disease}},
  booktitle = {Molecular},
  year = {2014},
  doi = {10.3892/mmr.2014.2254},
}
Figure